ART/HIV questions Flashcards
how many drugs are usually used in ART to treat HIV?
1
2
3
4
3 drugs are usually used combination to treat HIV
what class of drugs makes up the ‘backbone’ of ART Rx?
a) NNRTI (non nucleoside reverse transcriptase inhibitor)
b) NRTI (nucleoside reverse transcriptase inhibitor)
c) PI (protease inhibitor)
d) INI (intergrase inhibitor)
b - NRTI (commonly truvada - tenofovir DF + emtricitabine)
what is the first line ART backbone in treatment of HIV in therapy naive patients (assuming no co-morbidities, no drug interactions etc)
tenofovir DF + emtricitabine (truvada) plus a third agent e.g raltegravir
A patient is noted to have a HLA B 75:01 positive result. Which of the following ARTs are contra-indicated?
a) tenofovir
b) efavirenz
c) abacavir
d) rilpivirine
c - abacavir
When is rilpivirine generally only recommended at baseline rx for HIV?
when VL > 100,000 copies at baseline
if first line standard NRTI backbone (truvada) is contra-indicated what is an alternative first line option that could be used for therapy naive patients?
when is this option recommended in patients diagnosed with HIV and not already on ART?
Abacavir + Lamivudine (3TC = kivexa)
plus efavirenz
if VL>100,000 copies/mL then abacavir + lamivudine (3TC - kivexa) is recommended
at what CrCL level is Tenofovir DF contra-indicated?
CrCL <70
At what CrCL if tenofovir-AF contra-indicated?
CrCL < 30
what did the PARTNER study show?
no risk of HIV transmission between serodiscordant couples when VL < 200 (undetectable = untransmissable (u=u))
list 4 situations when you would consider changing the ART regime
- viral load becomes detectable i.e. vial rebound
- side effects
drug interactions
drug resistance
what is the definition of a viral blip
when the HIV viral load becomes detectable on ART for a short period of time (no need to change meds if VL subsequently goes back to being undetectable)
If the VL goes above 200 copies/ml what should you do?
investigate for drug resistance if pt states they are complying with treatment
if it is sustained VL rebound then you should consider the need to change ART
what is the ART first line for patients with HIV and TB co-infection?
tenofovir -DF + emtricitabine (truvada) + efavirenz
A patient is diagnosed with HIV and TB co-infection. They are not on ART for HIV. Their CD4 count comes back at 24. how would you manage their TB and HIV, how quickly should ART be started?
a) start ART immediately prior to TB treatment
b) start TB treatment first, aim to start ART within 2 weeks once established on TB treatment
c) just start ART once established on ART then worry about TB Rx
d) delay ART for up to 8-12 weeks, focus on TB treatment for now.
b- start TB treatment with the aim to start ART within 2 weeks
Ben is diagnosed with HIV and TB co-infection. these are both new diagnoses and he is not currently on any treatment. His CD4 count comes back at 87 and VL 500.
How would you manage the TB and HIV treatment?
a) simultaneously start TB and ART treatment
b) start TB treatment and delay initiation of ART for 8-12 weeks
c) start ART once established then start TB once Ben is ready
d) start TB treatment, only start ART once he has completed TB treatment
b) start TB treatment - delay starting ART for 8-12 weeks
Jodie is admitted unwell with severe confusion and pyrexia of unknown origin. LP demonstrates CNS TB and her HIV blood test comes back positive. She was previously known to have HIV but was lost to follow up and is not on any HIV medication. Her VL is 87,000 and CD4 count 43.
How would you manage the TB and HIV co-infection?
a) simultaneously start TB and ART treatment
b) start TB treatment and delay initiation ART after 8 weeks
c) start ART once established then start TB once Ben is ready
d) start TB treatment, only start ART once he has completed TB treatment
b - start TB treatment and delay ART initiation regardless of CD4 count for minimum of 8 weeks
Which ART should be avoided in patients with neurocognitive impairment or mental health illnesses including depression and anxiety?
a) Efavirenze
b) Tenofovir
c) Emtricitabine
d) Raltegravir
a- efavirenze
which of the following ART should be avoided in patients with known CKD?
a) Efavirenze
b) Tenofovir -DF
c) Emtricitabine
d) Raltegravir
b - tenofovir DF
a patient has a QRisk 3 score of 10 and is on treatment for unstable angina. Which of the following ART medications should be avoided in the treatment of his HIV?
a) Efavirenze
b) Tenofovir
c) Emtricitabine
d) Abacavir
Abacavir - should be avoided in patients who have risk factors for CVD.
John is 47 years old and has been diagnosed with HIV. Whilst taking a drug history he mentions he is on regular bisphosphonates for treatment of osteoporosis that was picked up following the diagnosis of a fragility fracture. Which ART treatment should be avoided in patients with reduced bone mineral denisity?
a) Efavirenze
b) Tenofovir
c) Emtricitabine
d) Raltegravir
b - tenofovir
list the three AIDS defining malignancies
a) KS (Kaposi Sarcoma)
b) NHL - typically diffuse large B cell lymphoma or Burkitt’s lymphoma
c) Cerivcal cancer
Is anal cancer an AIDs defining malignancy in men with HIV
no - but it is 2-3 times more common in men who are HIV +ve
In patients diagnosed with an AIDS defining malignancy, when should they start ART if not already established on Rx?
a) immediately
b) once established on chemotherapy or radiotherapy
c) never - treat the malignancy first
a - immediately. all patients with AIDS defining malignancies should be started on ART immediately
In a patient with an aids defining malignancy due to start cancer treatment when would you consider starting HSV prophylaxis and PCP prophylaxis?
start HSV prophylaxis if they have a history of HSV due to start cancer Rx (otherwise not indicated)
PCP prophylaxis if CD4 count < 200 then start PCP prophylaxis (co-trimoxazole 960mg OD three times a week)